375
Views
7
CrossRef citations to date
0
Altmetric
Original Article

An Ex Vivo Model for Suture-Less Amniotic Membrane Transplantation with a Chemically Defined Bioadhesive

, , , , , , , & show all
Pages 372-380 | Received 30 Jun 2011, Accepted 30 Jan 2012, Published online: 29 Mar 2012

REFERENCES

  • Ollivier FJ, Kallberg ME, Plummer CE et al. Amniotic membrane transplantation for corneal surface reconstruction after excision of corneolimbal squamous cell carcinomas in nine horses. Vet Ophthalmol. 2006;9:404–413.
  • Plummer CE, Ollivier FJ, Kallberg ME, Brooks DE, Barrie K, Utter M, Gelatt K. The use of amniotic membrane transplantation for ocular surface reconstruction: A review and series of 58 equine clinical cases (2002–2008). Vet Ophthalmol. 2009;12:17–24.
  • Brooks DE, Mathews AG. (2007). Equine ophthalmology. In: Gelatt KN ed Veterinary Ophthalmology. 4th ed. Iowa: Blackwell Publishing, 1192–1225.
  • Gilger BC, Whitley RD. (1999). Surgery of the cornea and sclera. In: Gelatt KN ed Veterinary Ophthalmology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 675–754.
  • Miklós DR, Ursula SS, Carmen HR, et al. Adhesion structures of amniotic membranes integrated into human corneas. IOVS. 2006;47:1853–1861.
  • Kruse FE, Rohrschneider K, Völcker HE. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers. Ophthalmology. 1999;106:1504–10; discussion 1511.
  • Shimazaki J, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophthalmology. 1997;104:2068–2076.
  • Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303–312.
  • Letko E, Stechschulte SU, Kenyon KR et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol. 2001;119:659–663.
  • Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122:38–52.
  • Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82:235–240.
  • Ti SE, Chee SP, Dear KB, Tan DT. Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol. 2000;84:385–389.
  • Ollivier FJ. Medical and surgical management of melting corneal ulcers exhibiting hyperproteinase activity in the horse. Clin Tech Equine Pract. 2005;4:50–71.
  • Lassaline ME, Brooks DE, Ollivier FJ, Komaromy AM, Kallberg ME, Gelatt KN. Equine amniotic membrane transplantation for corneal ulceration and keratomalacia in three horses. Vet Ophthalmol. 2005;8:311–317.
  • Barros PS, Garcia JA, Laus JL, Ferreira AL, Salles Gomes TL. The use of xenologous amniotic membrane to repair canine corneal perforation created by penetrating keratectomy. Vet Ophthalmol. 1998;1:119–123.
  • Barros PS, Safatle AM, Godoy CA, Souza MS, Barros LF, Brooks DE. Amniotic membrane transplantation for the reconstruction of the ocular surface in three cases. Vet Ophthalmol. 2005;8:189–192.
  • Barachetti L, Giudice C, Mortellaro CM. Amniotic membrane transplantation for the treatment of feline corneal sequestrum: pilot study. Vet Ophthalmol. 2010;13:326–330.
  • Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124:765–774.
  • Connon CJ, Nakamura T, Quantock AJ, Kinoshita S. The persistence of transplanted amniotic membrane in corneal stroma. Am J Ophthalmol. 2006;141:190–192.
  • Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995;14:473–484.
  • Dua HS, Azuara-Blanco A. Amniotic membrane transplantation. Br J Ophthalmol. 1999;83:748–752.
  • Takaoka M, Nakamura T, Sugai H et al. Sutureless amniotic membrane transplantation for ocular surface reconstruction with a chemically defined bioadhesive. Biomaterials. 2008;29:2923–2931.
  • Takaoka M, Nakamura T, Sugai H et al. Novel sutureless keratoplasty with a chemically defined bioadhesive. Invest Ophthalmol Vis Sci. 2009;50:2679–2685.
  • Egorov VI, Schastlivtsev V, Turusov RA, Baranov AO. Participation of the intestinal layers in supplying of the mechanical strength of the intact and sutured gut. Eur Surg Res. 2002;34:425–431.
  • Sharma A, Kaur R, Kumar S et al. Fibrin glue versus N-butyl-2-cyanoacrylate in corneal perforations. Ophthalmology. 2003;110:291–298.
  • Szurman P, Warga M, Grisanti S et al. Sutureless amniotic membrane fixation using fibrin glue for ocular surface reconstruction in a rabbit model. Cornea. 2006;25:460–466.
  • Nakajima N, Sugai H, Tsutsmi S, Hyon S-H. Self-degradable bioadhesive. Key Eng Mater. 2007;342–343:713–716.
  • Dylan GB, Elizabeth AG, Ajay S, Rajiv RM. Isolation and cultivation of equine corneal keratocytes, fibroblasts and myofibroblasts. Vet Ophthalmol. 2010;13:37–42.
  • Duchesne B, Tahi H, Galand A. Use of human fibrin glue and amniotic membrane transplant in corneal perforation. Cornea. 2001;20:230–232.
  • Hino M, Ishiko O, Honda KI et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol. 2000;108:194–195.
  • Kawamura M, Sawafuji M, Watanabe M, Horinouchi H, Kobayashi K. Frequency of transmission of human parvovirus B19 infection by fibrin sealant used during thoracic surgery. Ann Thorac Surg. 2002;73:1098–1100.
  • Taylor DM. Inactivation of TSE agents: safety of blood and blood-derived products. Transfus Clin Biol. 2003;10:23–25.
  • Webster RG Jr, Slansky HH, Refojo MF, Boruchoff SA, Dohlman CH. The use of adhesive for the closure of corneal perforations. Report of two cases. Arch Ophthalmol. 1968;80:705–709.
  • Tseng YC, Tabata Y, Hyon SH, Ikada Y. In vitro. toxicity test of 2-cyanoacrylate polymers by cell culture method. J Biomed Mater Res. 1990;24:1355–1367.
  • Bhatia SS. Ocular surface sealants and adhesives. Ocul Surf. 2006;4:146–154.
  • Hiraki J, Ichikawa T, Ninomiya S et al. Use of ADME studies to confirm the safety of epsilon-polylysine as a preservative in food. Regul Toxicol Pharmacol. 2003;37:328–340.
  • Chegel V, Shirshov Y, Avilov S, Demchenko M, Mustafaev M. A novel aldehyde dextran sulfonate matrix for affinity biosensors. J Biochem Biophys Methods. 2002;50:201–216.
  • Shima S, Matsuoka H, Iwamoto T, Sakai H. Antimicrobial action of epsilon-poly-L-lysine. J Antibiot. 1984;37:1449–1455.
  • Whitcomb JE, Barnett VA, Olsen TW, Barocas VH. Ex vivo porcine iris stiffening due to drug stimulation. Exp Eye Res. 2009;89:456–461.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.